There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

Researchers find that xylazine test strips are powerful harm reduction tools, but have some significant limitations to be ...

Alzheimer's disease plagues South Carolina, with more than 112,00 patients and a high death rate. New blood test analyzers at ...